ARCHIVES

In Brief: Wyeth-Ayerst To donate hormone Replacement Therapy To NIH For Women’s Health Initiative

This article is from The Cancer Letter archive.

Vol. 19 No. 17 | April 23, 1993

Download PDF Visit The Full Archive

Related Articles

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Senate Committee Adds $100 Million for Cancer, Earmarks Extra Positions for NCI, Backs New Construction

September 19, 1975

In Congress: $135 Million Expected For DOD Breast Cancer Research Program

July 24, 1998

Change In Method Of Counting Cancer Incidence Results In More Attributed To Work Hazards

October 6, 1978

HHS Pick For FDA May Be Food Safety Expert.

October 5, 2001

Is the Concept of National Chain Of Outpatient Centers Still Viable?

May 2, 1997